Drag: Crystalloids and Colloids
Phase 1Small molecule
Drag: Crystalloids and Colloids is one of 21 small molecule programs targeting Abdominal Aortic Aneurysm. It is currently in Phase 1.
1
Indications
1
Total Trials
0
Active Trials
20
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
30 competitors in Abdominal Aortic Aneurysm
#DrugCompanyPhaseTrials
1Neoral
NovartisApproved
MS Contin
HHikma Pharmaceuticals LLC
Approved
Micardis
Boehringer IngelheimApproved
Precedex
MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
Approved
Lipitor
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Approved
Inspra
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Approved
Paracetamol
GSKApproved
Cyklokapron
AAmring
Phase 3
Curcumin
Merck & Co.Phase 3
Brilinta
AstraZenecaPhase 2
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 1[1]
- Company
- UUniversity Clinical Center Tuzla